These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18251702)

  • 1. Interleukin-4 and interleukin-13 stimulate the osteoclast inhibitor osteoprotegerin by human endothelial cells through the STAT6 pathway.
    Stein NC; Kreutzmann C; Zimmermann SP; Niebergall U; Hellmeyer L; Goettsch C; Schoppet M; Hofbauer LC
    J Bone Miner Res; 2008 May; 23(5):750-8. PubMed ID: 18251702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
    Luo XH; Guo LJ; Xie H; Yuan LQ; Wu XP; Zhou HD; Liao EY
    J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
    Viereck V; Emons G; Lauck V; Frosch KH; Blaschke S; Gründker C; Hofbauer LC
    Biochem Biophys Res Commun; 2002 Mar; 291(3):680-6. PubMed ID: 11855844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H; Guo J; Bringhurst FR
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.
    Tunyogi-Csapo M; Kis-Toth K; Radacs M; Farkas B; Jacobs JJ; Finnegan A; Mikecz K; Glant TT
    Arthritis Rheum; 2008 Aug; 58(8):2397-408. PubMed ID: 18668542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.
    Nakashima T; Kobayashi Y; Yamasaki S; Kawakami A; Eguchi K; Sasaki H; Sakai H
    Biochem Biophys Res Commun; 2000 Sep; 275(3):768-75. PubMed ID: 10973797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
    Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
    Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes.
    Kim YG; Lee CK; Oh JS; Kim SH; Kim KA; Yoo B
    Arthritis Rheum; 2010 Feb; 62(2):515-23. PubMed ID: 20112365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependent.
    Schoppet M; Henser S; Ruppert V; Stübig T; Al-Fakhri N; Maisch B; Hofbauer LC
    J Cell Biochem; 2007 Apr; 100(6):1430-9. PubMed ID: 17171649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
    Kon T; Cho TJ; Aizawa T; Yamazaki M; Nooh N; Graves D; Gerstenfeld LC; Einhorn TA
    J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
    Wada N; Maeda H; Yoshimine Y; Akamine A
    Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway.
    Chamoux E; Houde N; L'Eriger K; Roux S
    J Cell Physiol; 2008 Aug; 216(2):536-42. PubMed ID: 18338379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels.
    Kondo T; Kitazawa R; Yamaguchi A; Kitazawa S
    J Cell Biochem; 2008 Jan; 103(1):335-45. PubMed ID: 17516544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin and inflammation.
    Saidenberg Kermanac'h N; Bessis N; Cohen-Solal M; De Vernejoul MC; Boissier MC
    Eur Cytokine Netw; 2002; 13(2):144-53. PubMed ID: 12101070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further insights in the mechanisms of interleukin-1beta stimulation of osteoprotegerin in osteoblast-like cells.
    Lambert C; Oury C; Dejardin E; Chariot A; Piette J; Malaise M; Merville MP; Franchimont N
    J Bone Miner Res; 2007 Sep; 22(9):1350-61. PubMed ID: 17501665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-4 inhibition of osteoclast differentiation is stronger than that of interleukin-13 and they are equivalent for induction of osteoprotegerin production from osteoblasts.
    Yamada A; Takami M; Kawawa T; Yasuhara R; Zhao B; Mochizuki A; Miyamoto Y; Eto T; Yasuda H; Nakamichi Y; Kim N; Katagiri T; Suda T; Kamijo R
    Immunology; 2007 Apr; 120(4):573-9. PubMed ID: 17343616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland.
    Hofbauer LC; Kluger S; Kühne CA; Dunstan CR; Burchert A; Schoppet M; Zielke A; Heufelder AE
    J Cell Biochem; 2002; 86(4):642-50. PubMed ID: 12210731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory roles of beta-catenin and AP-1 on osteoprotegerin production in interleukin-1alpha-stimulated periodontal ligament cells.
    Suda T; Nagasawa T; Wara-Aswapati N; Kobayashi H; Iwasaki K; Yashiro R; Hormdee D; Nitta H; Ishikawa I; Izumi Y
    Oral Microbiol Immunol; 2009 Oct; 24(5):384-9. PubMed ID: 19702951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.